Zarzuelo-Romero, M.J.; PĂ©rez-RamĂrez, C.; Cura, Y.; Carrasco-Campos, M.I.; Marangoni-Iglecias, L.M.; RamĂrez-Tortosa, M.C.; JimĂ©nez-Morales, A.
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. J. Pers. Med. 2021, 11, 1032.
https://doi.org/10.3390/jpm11101032
AMA Style
Zarzuelo-Romero MJ, PĂ©rez-RamĂrez C, Cura Y, Carrasco-Campos MI, Marangoni-Iglecias LM, RamĂrez-Tortosa MC, JimĂ©nez-Morales A.
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Journal of Personalized Medicine. 2021; 11(10):1032.
https://doi.org/10.3390/jpm11101032
Chicago/Turabian Style
Zarzuelo-Romero, MarĂa JosĂ©, Cristina PĂ©rez-RamĂrez, YasmĂn Cura, MarĂa Isabel Carrasco-Campos, Luciana MarĂa Marangoni-Iglecias, MarĂa Carmen RamĂrez-Tortosa, and Alberto JimĂ©nez-Morales.
2021. "Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients" Journal of Personalized Medicine 11, no. 10: 1032.
https://doi.org/10.3390/jpm11101032
APA Style
Zarzuelo-Romero, M. J., PĂ©rez-RamĂrez, C., Cura, Y., Carrasco-Campos, M. I., Marangoni-Iglecias, L. M., RamĂrez-Tortosa, M. C., & JimĂ©nez-Morales, A.
(2021). Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Journal of Personalized Medicine, 11(10), 1032.
https://doi.org/10.3390/jpm11101032